Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 128
Filter
1.
Bone Rep ; 7: 137-144, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29124084

ABSTRACT

Second-harmonic generation imaging (SHG) captures triple helical collagen molecules near tissue surfaces. Biomedical research routinely utilizes various imaging software packages to quantify SHG signals for collagen content and distribution estimates in modern tissue samples including bone. For the first time using SHG, samples of modern, medieval, and ice age bones were imaged to test the applicability of SHG to ancient bone from a variety of ages, settings, and taxa. Four independent techniques including Raman spectroscopy, FTIR spectroscopy, radiocarbon dating protocols, and mass spectrometry-based protein sequencing, confirm the presence of protein, consistent with the hypothesis that SHG imaging detects ancient bone collagen. These results suggest that future studies have the potential to use SHG imaging to provide new insights into the composition of ancient bone, to characterize ancient bone disorders, to investigate collagen preservation within and between various taxa, and to monitor collagen decay regimes in different depositional environments.

2.
J Ayub Med Coll Abbottabad ; 22(4): 3-5, 2010.
Article in English | MEDLINE | ID: mdl-22455249

ABSTRACT

BACKGROUND: Rapid Access Chest Pain Clinics (RACPCs) are set up to access patients with new onset chest pain (within the preceding three weeks), of possible cardiac origin. These patients are seen in the clinic within two weeks of referral and the attending physician takes a history, performs a routine clinical examination, and if clinically justified, a treadmill exercise test is performed according to Bruce Protocol. Within the group of patients referred to the RACPC with new onset but otherwise stable angina, there is a potential overlap with patients who in fact may have an evolving acute coronary syndrome, i.e., unstable angina. The aim of this study was to assess the prevalence of Troponin-I positivity as an indicator of acute coronary syndrome. METHODS: This cross-sectional descriptive study included 60 consecutive patients referred to the RACPC with history of recent onset chest pain (within the last three weeks) of possible cardiac origin and positive ETT or confirmed abnormal ischemic ECG at baseline. Troponin-L was measured in these patients. RESULTS: Out of the total 60 patients, 8.33% of the patients referred to RACPC with new onset angina had positive cTnI. CONCLUSION: Point of care test (POCT) for cTnI can help to identify the high risk patient referred to RACPC.


Subject(s)
Chest Pain/diagnosis , Troponin I/blood , Ambulatory Care Facilities , Angina Pectoris/diagnosis , Cross-Sectional Studies , Female , Health Services Accessibility , Humans , Male , Middle Aged , Pakistan , Point-of-Care Systems , Referral and Consultation/organization & administration
3.
J Virol ; 83(24): 12871-80, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19793816

ABSTRACT

Dengue virus (DENV) pathogenesis is related to the host responses to viral infection within target cells, and therefore, this study assessed intracellular changes in host proteins following DENV infection. Two-dimensional gel electrophoresis and mass spectrometry identified upregulation of the host endoplasmic reticulum (ER) chaperone GRP78 in K562 cells following DENV infection, in the absence of virus-induced cell death. Upregulation of GRP78 in DENV-infected cells was confirmed by immunostaining and confocal microscopy and by Western blot analysis and was also observed in DENV-infected primary monocyte-derived macrophages, a natural target cell type for DENV infection. GRP78 was upregulated in both DENV antigen-positive and -negative cells in the DENV-infected culture, suggesting a bystander effect, with the highest GRP78 levels coincident with high-level DENV antigen production and infectious-virus release. Transfection of target cells to express GRP78 prior to DENV challenge did not affect subsequent DENV infection, but cleavage of GRP78 with the SubAB toxin, during an established DENV infection, yielded a 10- to 100-fold decrease in infectious-virus release, loss of intracellular DENV particles, and a dramatic decrease in intracellular DENV antigen. However, DENV RNA levels were unchanged, indicating normal DENV RNA replication but altered DENV antigen levels in the absence of GRP78. Thus, GRP78 is upregulated by DENV infection and is necessary for DENV antigen production and/or accumulation. This may be a common requirement for viruses such as flaviviruses that depend heavily on the ER for coordinated protein production and processing.


Subject(s)
Antigens, Viral/biosynthesis , Dengue Virus/immunology , Dengue/metabolism , Heat-Shock Proteins/physiology , Animals , Chlorocebus aethiops , Dengue Virus/physiology , Endoplasmic Reticulum Chaperone BiP , Humans , K562 Cells , Up-Regulation , Vero Cells , Virus Replication
4.
Genes Immun ; 10(5): 397-403, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19369946

ABSTRACT

We targeted LYN, a src-tyosine kinase involved in B-cell activation, in case-control association studies using populations of European-American, African-American and Korean subjects. Our combined European-derived population, consisting of 2463 independent cases and 3131 unrelated controls, shows significant association with rs6983130 in a female-only analysis with 2254 cases and 2228 controls (P=1.1 x 10(-4), odds ratio (OR)=0.81 (95% confidence interval: 0.73-0.90)). This single nucleotide polymorphism (SNP) is located in the 5' untranslated region within the first intron near the transcription initiation site of LYN. In addition, SNPs upstream of the first exon also show weak and sporadic association in subsets of the total European-American population. Multivariate logistic regression analysis implicates rs6983130 as a protective factor for systemic lupus erythematosus (SLE) susceptibility when anti-dsDNA, anti-chromatin, anti-52 kDa Ro or anti-Sm autoantibody status were used as covariates. Subset analysis of the European-American female cases by American College of Rheumatology classification criteria shows a reduction in the risk of hematological disorder with rs6983130 compared with cases without hematological disorders (P=1.5 x 10(-3), OR=0.75 (95% CI: 0.62-0.89)). None of the 90 SNPs tested show significant association with SLE in the African American or Korean populations. These results support an association of LYN with European-derived individuals with SLE, especially within autoantibody or clinical subsets.


Subject(s)
Lupus Erythematosus, Systemic/genetics , Polymorphism, Single Nucleotide , src-Family Kinases/genetics , Age Factors , Case-Control Studies , Female , Genome-Wide Association Study , Humans , Lupus Erythematosus, Systemic/epidemiology , Lupus Erythematosus, Systemic/immunology
5.
Biosens Bioelectron ; 23(7): 1161-5, 2008 Feb 28.
Article in English | MEDLINE | ID: mdl-18054481

ABSTRACT

This report describes the fabrication and successful use of the ion channel switch biosensor (ICSB) for rapid point-of-care detection of influenza A in different types of respiratory specimens. Virus culture -- regarded as the "gold standard" -- and an immunochromatographic rapid point-of-care test for influenza A virus were compared with the biosensor. The ICSB rapid test provided an objective readout within 10 min of specimen inoculation into the ICSB chamber wells, without the need for chemical or other pretreatments. Construction of the ICSB with specific antibodies also enables rapid detection and identification of appropriate influenza A subtypes.


Subject(s)
Biosensing Techniques/instrumentation , Immunoassay/instrumentation , Influenza A virus/isolation & purification , Viral Load/instrumentation , Biosensing Techniques/methods , Computer Systems , Equipment Design , Equipment Failure Analysis , Humans , Immunoassay/methods , Ions , Reproducibility of Results , Sensitivity and Specificity , Viral Load/methods
6.
J Clin Microbiol ; 45(4): 1288-97, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17314225

ABSTRACT

We have adapted our established Alu PCR assay for proviral DNA and PCR for total cellular DNA to a real-time PCR format and applied these to human immunodeficiency virus (HIV)-positive specimens collected for routine determination of the plasma viral load (pVL). In a cohort of five patients, measurements of integrated viral load (iVL) and cell-associated viral load (cVL) in CD4(+) cells isolated by a single positive selection step were not indicative of HIV DNA levels in the circulation, and further analysis was performed on peripheral blood mononuclear cells (PBMC). In a cohort of 46 samples total cVL was quantitated in most samples, but iVL could be quantitated in only 47.8%, since in 26% iVL was undetectable and in 21.7% the results were invalid due to high levels of unintegrated HIV DNA. There was no correlation of cVL or iVL with pVL, CD4 count, or duration of successful antiretroviral treatment. Out of 26 patients with undetectable pVL, 4 patients failed therapy within the subsequent 12 months and had higher than average iVL, but this was not the case for cVL. Among nine patients with long-term undetectable pVL, no consistent decline in cVL or iVL was seen with time, and changes in cVL and iVL within a patient could be concordant or discordant. These results show that cVL and iVL can be coordinately measured in PBMC from clinical samples but do not correlate with pVL, CD4 counts, or length of suppressive antiretroviral therapy. Interestingly, a high iVL (but not a high cVL) in patients with undetectable pVL was associated with subsequent treatment failure.


Subject(s)
DNA, Viral/analysis , DNA, Viral/genetics , HIV Infections/virology , HIV-1/genetics , Proviruses/genetics , Virus Integration , Anti-HIV Agents/pharmacology , Anti-HIV Agents/therapeutic use , Blood/virology , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/virology , HIV Infections/drug therapy , Humans , Leukocytes, Mononuclear/virology , Polymerase Chain Reaction/methods , Prognosis , Viral Load/methods , Viremia
7.
Curr Drug Targets ; 7(12): 1583-93, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17168833

ABSTRACT

Vif is an HIV accessory protein whose primary function is to negate the action of APOBEC3G, a naturally occurring cellular inhibitor of HIV replication. Vif acts by binding to APOBEC3G, inducing its protein degradation within infected cells and reducing its levels in progeny virions. Interventions that interfere with the Vif-APOBEC3G interaction, raise intracellular or virion associated levels of APOBEC3G, or reduce intracellular levels of Vif, all could hold promise as potential therapeutic approaches aimed at enhancing the cells innate antiviral activity. Levels of APOBEC3G might be increased or Vif levels decreased, by strategies targeting protein synthesis, protein degradation or cellular localisation and function, and properties of APOBEC3G and Vif relevant to these strategies are discussed. Recent data have suggested that Vif may have other mechanisms of action apart from the above activities against APOBEC3G, including effects against other anti-viral mechanisms independent of APOBEC3G cytidine deaminase activity. In addition to interaction with APOBEC3G, Vif may have other accessory functions, which are discussed in relation to potential therapies that may affect multiple stages of the HIV life cycle. Future development of strategies that combine enhancement of APBOEC3G functional with inhibition of multiple Vif functions may become useful tools for HIV therapy.


Subject(s)
Anti-HIV Agents/pharmacology , Gene Products, vif/antagonists & inhibitors , Nucleoside Deaminases/physiology , Repressor Proteins/physiology , APOBEC-3G Deaminase , Acetyltransferases/physiology , Cytidine Deaminase , Drug Resistance, Viral , Gene Products, vif/metabolism , HIV Protease/metabolism , Humans , Intracellular Signaling Peptides and Proteins/physiology , Phenotype , Protein Binding , Proto-Oncogene Proteins c-hck/physiology , Ubiquitin-Protein Ligases , Virus Assembly , Virus Replication
8.
J Cardiovasc Surg (Torino) ; 47(5): 589-91, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17033609

ABSTRACT

Adult cardiac surgery in patients with malrotation of the heart is rare. A 60 year-old lady, with known cardiac dextroversion, presented with dyspnoea and pre-syncopal attacks. Echocardiographical and radiological investigation confirmed the dextroversion, with clockwise rotation of the heart through its longitudinal axis. This resulted in the right ventricular outflow tract and pulmonary artery being wrapped anteriorly around the aorta, with posterior displacement of the right atrium. The presence of a heavily calcified, bicuspid aortic valve and dilated ascending aorta was also demonstrated. At surgery, venous cannulation was established by rotating the heart anticlockwise and access to the aortic valve gained with a more superior oblique aortotomy. In the presence of a dilated ascending aorta with a calcified, bicuspid aortic valve, the aortic root was replaced with a valved conduit. To the authors' knowledge, this is the first report of an aortic root replacement in a patient with cardiac dextroversion.


Subject(s)
Aortic Diseases/surgery , Aortic Valve , Calcinosis/surgery , Dextrocardia/complications , Heart Valve Diseases/surgery , Heart Valve Prosthesis Implantation/methods , Vascular Surgical Procedures/methods , Aorta, Thoracic , Aortic Diseases/complications , Aortic Diseases/diagnostic imaging , Calcinosis/complications , Calcinosis/diagnostic imaging , Dextrocardia/diagnostic imaging , Dilatation, Pathologic , Female , Follow-Up Studies , Heart Valve Diseases/complications , Heart Valve Diseases/diagnostic imaging , Humans , Middle Aged , Tomography, X-Ray Computed
9.
Virology ; 351(1): 80-91, 2006 Jul 20.
Article in English | MEDLINE | ID: mdl-16631224

ABSTRACT

Reverse transcription (RTn) in HIV-infected cells occurs in a nucleoprotein complex termed the reverse transcription complex (RTC). RTCs containing RT activity and integrase (IN) were shown to be heterogeneous in size and density on sucrose velocity and equilibrium gradients. WT and Vif-deficient (Deltavif) RTCs produced by infection with virus from permissive cells displayed similar sedimentation characteristics, while RTCs from Deltavif virus produced in non-permissive cells demonstrated a reduction in the major RTC form and more of the RTn products in rapidly sedimenting structures. APOBEC3G derived from virions did not co-sediment with RTCs, but RTCs from Deltavif infections showed elevated levels of mutations in RTn products, consistent with APOBEC3G and other mutational mechanisms. The most mutated transcripts were present within rapidly sedimenting RTCs. Thus, virus without functional vif, produced from non-permissive cells, forms abnormal RTCs that contain increased mutation of RTC-associated RTn products in newly infected target cells.


Subject(s)
Gene Products, vif/deficiency , HIV Reverse Transcriptase/chemistry , HIV Reverse Transcriptase/metabolism , Mutation/genetics , Reverse Transcription , APOBEC-3G Deaminase , Cell Line , Cell-Free System , Cytidine Deaminase , Gene Products, vif/metabolism , Humans , Multiprotein Complexes/chemistry , Multiprotein Complexes/metabolism , Mutagenesis , Nucleoside Deaminases/metabolism , Repressor Proteins/metabolism
10.
Intern Med J ; 35(11): 672-4, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16248862

ABSTRACT

Hantavirus antibody-positive rodents have been found across Australia although, to date, there are no reports of infections in humans. This could be due to misdiagnosis clinically and/or inadequate laboratory technique/skills. There are close trading ties between Australia and Asian countries as well as our geographical neighbours where both human and rodent infections are found, so importation is a continuing threat. We consider that further sero-epidemiological surveys are warranted among rodents (especially those captured from ports in Australia), in patients from renal and respiratory wards of hospitals, and in residents and employees close to harbours using more specific and sensitive laboratory techniques than have been available in the past.


Subject(s)
Disease Reservoirs , Hantavirus Infections/diagnosis , Hantavirus Infections/epidemiology , Population Surveillance/methods , Risk Assessment/methods , Australia/epidemiology , Hantavirus Infections/prevention & control , Risk Factors
11.
Postgrad Med J ; 81(957): 459-62, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15998823

ABSTRACT

OBJECTIVE: To record disease progression and the timing of adverse events in patients on a waiting list for elective percutaneous coronary intervention (PCI). DESIGN: Observational prospective study. SETTINGS: A UK tertiary cardiothoracic centre, at a time when waiting lists for PCI were up to 18 months. PATIENTS: 145 patients (116 men, median age 59.5 years) placed on an elective waiting list for PCI between October 1998 and September 1999. MAIN OUTCOME MEASURES: Adverse events recorded were death, myocardial infarction, need for urgent hospital admission because of unstable angina, and need for emergency revascularisation while waiting for PCI. RESULTS: During a median follow up of 10 months (range 1-18 months), nine (6.2%) patients experienced an adverse event. Eight (5.52%) patients were admitted with unstable angina as emergencies. One was admitted with a myocardial infarction. Twenty nine (20.0%) patients had significant disease progression at the time of the repeat angiogram before PCI. In 10 (7%), disease had progressed so that PCI was no longer feasible and patients were referred for coronary artery bypass graft. Sixteen (11%) were removed from the PCI waiting list because of almost complete resolution of their anginal symptoms. CONCLUSION: Adverse coronary events and clinically significant disease progression occur commonly in patients waiting for PCI. Despite the presence of severe coronary lesions, myocardial infarction was rare and no patients died while on the waiting list. Resolution of anginal symptoms was also comparatively common. The pathophysiology of disease progression frequently necessitates a change in the treatment of patients waiting for PCI.


Subject(s)
Angioplasty, Balloon, Coronary , Coronary Disease/therapy , Waiting Lists , Adult , Aged , Collateral Circulation , Coronary Disease/complications , Coronary Disease/pathology , Disease Progression , Elective Surgical Procedures , Emergencies , England , Female , Follow-Up Studies , Hospitalization , Humans , Male , Middle Aged , Prognosis , Prospective Studies , Remission, Spontaneous
13.
Virology ; 317(2): 291-8, 2003 Dec 20.
Article in English | MEDLINE | ID: mdl-14698667

ABSTRACT

Hepadnaviruses including human hepatitis B virus (HBV) and duck hepatitis B virus (DHBV) express X proteins, HBx and DHBx, respectively. Both HBx and DHBx are transcriptional activators and modulate cellular signaling in in vitro assays. To test whether the DHBx protein plays a role in virus infection, we compared the in vivo infectivity and growth characteristics of a DHBV3 strain with a stop codon in the X-like ORF (DHBV3-X-K.O.) to those of the wild-type DHBV3 strain. Here we report that the two strains showed no significant difference in (i). their ability to induce infection that resulted in stable viraemia measured by serum surface antigen (DHBsAg) and DHBV DNA, and detection of viral proteins and replicative DNA intermediates in the liver; (ii). the rate of spread of infection in liver and extrahepatic sites after low-dose virus inoculation; and (iii). the ability to produce transient or persistent infection under balanced age/dose conditions designed to detect small differences between the strains. Thus, none of the infection parameters assayed were detectably affected by the X-ORF knockout mutation, raising the question whether DHBx expression plays a physiological role during in vivo infection with wild-type DHBV.


Subject(s)
Bird Diseases/virology , Gene Deletion , Hepadnaviridae Infections/veterinary , Hepatitis B Virus, Duck/pathogenicity , Hepatitis, Viral, Animal/virology , Trans-Activators/genetics , Animals , Bird Diseases/physiopathology , DNA, Viral/blood , Ducks , Hepadnaviridae Infections/physiopathology , Hepadnaviridae Infections/virology , Hepatitis B Surface Antigens/blood , Hepatitis B Virus, Duck/genetics , Hepatitis B Virus, Duck/metabolism , Hepatitis, Viral, Animal/physiopathology , Humans , Liver/metabolism , Liver/virology , Open Reading Frames , Trans-Activators/metabolism , Viral Proteins/metabolism , Viral Regulatory and Accessory Proteins , Viremia/virology
14.
J Virol ; 75(22): 11253-60, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11602768

ABSTRACT

We have developed a novel linker-primer PCR assay for the detection and quantification of integrated human immunodeficiency virus type 1 (HIV) DNA. This assay reproducibly allowed the detection of 10 copies of integrated HIV DNA, in a background of 2 x 10(5) cell equivalents of human chromosomal DNA, without amplifying extrachromosomal HIV DNA. We have used this assay and a near-synchronous one-step T-cell infection model to investigate the kinetics of viral DNA accumulation following HIV infection. We report here that integrated HIV DNA started accumulating 1 h after the first appearance of extrachromosomal viral DNA and accounted for approximately 10% of the total HIV DNA synthesized in the first round of viral replication. These results highlight the efficient nature of integrase-mediated HIV integration in infected T cells.


Subject(s)
DNA, Viral/analysis , HIV-1/genetics , T-Lymphocytes/virology , Virus Integration , Cell Line , Humans , Kinetics , Polymerase Chain Reaction , Virus Replication
15.
Antimicrob Agents Chemother ; 45(9): 2510-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11502522

ABSTRACT

To study the effect of potential human immunodeficiency virus type 1 (HIV-1) integrase inhibitors during virus replication in cell culture, we used a modified nested Alu-PCR assay to quantify integrated HIV DNA in combination with the quantitative analysis of extrachromosomal HIV DNA. The two diketo acid integrase inhibitors (L-708,906 and L-731,988) blocked the accumulation of integrated HIV-1 DNA in T cells following infection but did not alter levels of newly synthesized extrachromosomal HIV DNA. In contrast, we demonstrated that L17 (a member of the bisaroyl hydrazine family of integrase inhibitors) and AR177 (an oligonucleotide inhibitor) blocked the HIV replication cycle at, or prior to, reverse transcription, although both drugs inhibited integrase activity in cell-free assays. Quercetin dihydrate (a flavone) was shown to not have any antiviral activity in our system despite reported anti-integration properties in cell-free assays. This refined Alu-PCR assay for HIV provirus is a useful tool for screening anti-integration compounds identified in biochemical assays for their ability to inhibit the accumulation of integrated HIV DNA in cell culture, and it may be useful for studying the effects of these inhibitors in clinical trials.


Subject(s)
DNA, Viral/drug effects , HIV Integrase Inhibitors/pharmacology , HIV Integrase/metabolism , HIV-1/drug effects , Acetoacetates/pharmacology , Cells, Cultured , DNA, Viral/physiology , HIV Integrase/drug effects , HIV-1/enzymology , HIV-1/physiology , Humans , Hydrazines/pharmacology , Microbial Sensitivity Tests , Oligonucleotides/pharmacology , Virus Replication
17.
Virology ; 265(2): 319-29, 1999 Dec 20.
Article in English | MEDLINE | ID: mdl-10600603

ABSTRACT

Macrophages are considered of central importance in cell-to-cell transmission of human immunodeficiency virus (HIV) infection in vivo. In this report, we describe a novel cell-to-cell transmission model using HIV-infected monocyte-derived macrophages (MDMs) as donor cells and peripheral blood lymphocytes (PBLs) as recipients. Virus was transmitted during a 2-h coincubation period from intracellular or tightly cell-associated viral stores in adherent infected MDMs to nonadherent CD3(+) PBLs. Transmission required cell contact, but syncytia formation was not observed. HIV cell-to-cell transmission occurred in both allogeneic and autologous systems, and replication was higher in phytohemagglutinin (PHA)-stimulated than unstimulated recipient PBLs. In contrast, transmission of infection by cell-free virus was barely detectable without PHA stimulation of recipients, suggesting the cell-cell interaction may have provided stimuli to recipient cells in the cell-to-cell system. Viral DNA levels increased 5-24 h postmixing, and this increase was inhibited by pretreatment of cells with the reverse transcription inhibitor azidothymidine, indicating de novo reverse transcription was involved. Cell-to-cell transmission was more efficient than infection with cell-free virus released from donor MDMs, or 0.1 TCID(50)/cell cell-free viral challenge. This model provides a system to further investigate the mechanisms and characteristics of HIV cell-to-cell transmission between relevant primary cells that may be analogous to this important mode of virus spread in vivo.


Subject(s)
HIV-1/physiology , Lymphocytes/virology , Macrophages/virology , Cells, Cultured , DNA, Viral/biosynthesis , HIV-1/genetics , Humans , Kinetics , Lymphocytes/cytology , Lymphocytes/drug effects , Macrophages/cytology , Macrophages/drug effects , Macrophages/ultrastructure , Mitogens/pharmacology , Monocytes/cytology , Monocytes/drug effects , Monocytes/virology , Phytohemagglutinins/pharmacology , Time Factors
18.
Heart ; 82(4): 526-7, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10490575

ABSTRACT

Iatrogenic aneurysms are usually postcatheterisation pseudoaneurysms of the femoral artery. Until recently, the treatment of choice was ultrasound guided compression repair. A case of pseudoaneurysm of the axillary artery, arising as a complication of pacemaker insertion in an 83 year old man is reported. Compression repair was not possible in this case, and so the aneurysm was occluded by percutaneous ultrasound guided thrombin injection directly into the aneurysm sac. Percutaneous ultrasound guided thrombin injection is a promising new minimally invasive technique for the treatment of iatrogenic pseudoaneurysms.


Subject(s)
Aneurysm, False/drug therapy , Femoral Artery , Hemostatics/administration & dosage , Iatrogenic Disease , Thrombin/administration & dosage , Aged , Aged, 80 and over , Aneurysm, False/diagnostic imaging , Angiography, Digital Subtraction , Aortic Valve Stenosis/complications , Aortic Valve Stenosis/surgery , Aortic Valve Stenosis/therapy , Cardiac Pacing, Artificial/adverse effects , Femoral Artery/diagnostic imaging , Humans , Injections, Intra-Arterial , Male , Radiography, Interventional , Ultrasonography
19.
J Gen Virol ; 80 ( Pt 8): 2127-2135, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10466812

ABSTRACT

This paper describes the use of one-step growth conditions to study the kinetics of duck hepatitis B virus (DHBV) replication in primary duck hepatocytes. Synchronized infection was achieved using partially purified DHBV virions at an m.o.i. of 640 DHBV DNA-containing virions per cell, and these conditions were shown to produce a single cycle of infection. In this model, input purified DHBV DNA was rapidly internalized by cells at > or = 0.5 h, and localized to the nucleus by 4 h, but both covalently closed circular (CCC) DNA and single-stranded DNA were not detected until 48 h postinoculation (p.i.), suggesting that there was a > or = 40 h delay between DHBV localization to the nucleus and formation of CCC DNA. In contrast, CCC DNA can be first detected in hepatocytes at 6 h p.i. in in vivo infection of ducks with the same DHBV strain. In an analysis of the nuclear transport of the DHBV genome, release of nuclear viral DNA from a particulate form to a soluble nucleoplasmic form was only 50% complete by 48 h p.i. However, this process occurred simultaneously with genome uncoating since all soluble nucleoplasmic DHBV DNA was free of nucleocapsid material; this suggests that nucleocapsid disassembly and genome uncoating may occur at the nuclear membrane and not within the nucleus. Quantitative analysis demonstrated inefficiency in a number of steps including virus uptake and internalization, translocation of nucleocapsid across the nuclear membrane and antigen expression from intranuclear viral DNA.


Subject(s)
Hepatitis B Virus, Duck/physiology , Liver/virology , Virus Replication , Animals , Biological Transport , Cell Nucleus/virology , Cells, Cultured , DNA Replication , DNA, Viral/metabolism , Ducks , Hepatitis B Virus, Duck/genetics , Hepatitis B Virus, Duck/growth & development , Kinetics , Liver/cytology , Virus Replication/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...